SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marybeth Camboni, Chiou-Miin Wang, Carlos Miranda, Jung Hae Yoon, Rui Xu, Deborah Zygmunt, Brian K. Kaspar, Paul T. Martin, Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease, Neurobiology of Disease, 2014, 62, 31

    CrossRef

  2. 2
    M. Izco, P. Martínez, A. Corrales, N. Fandos, S. García, D. Insua, M. Montañes, V. Pérez-Grijalba, N. Rueda, V. Vidal, C. Martínez-Cué, P. Pesini, M. Sarasa, Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer’s disease, Neuroscience, 2014, 263, 269

    CrossRef

  3. 3
    Yvonne Bouter, Tim Kacprowski, Robert Weissmann, Katharina Dietrich, Henning Borgers, Andreas Brauß, Christian Sperling, Oliver Wirths, Mario Albrecht, Lars R. Jensen, Andreas W. Kuss, Thomas A. Bayer, Deciphering the Molecular Profile of Plaques, Memory Decline and Neuron Loss in Two Mouse Models for Alzheimer’s Disease by Deep Sequencing, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  4. 4
    Michelle G.K. Tan, Chingli Lee, Jasinda H. Lee, Paul T. Francis, Robert J. Williams, María J. Ramírez, Christopher P. Chen, Peter T.-H. Wong, Mitchell K.P. Lai, Decreased rabphilin 3A immunoreactivity in Alzheimer’s disease is associated with Aβ burden, Neurochemistry International, 2014, 64, 29

    CrossRef

  5. 5
    Eugene O'Hare, David I.C. Scopes, Eun-Mee Kim, Philip Palmer, David Spanswick, Bridgeen McMahon, Hozefa Amijee, Edmund Nerou, J. Mark Treherne, Ross Jeggo, Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's disease, The International Journal of Neuropsychopharmacology, 2014, 17, 01, 117

    CrossRef

  6. 6
    Cassia R. Overk, Eliezer Masliah, Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease, Biochemical Pharmacology, 2014, 88, 4, 508

    CrossRef

  7. You have free access to this content7
    Audrey Guilmatre, Guillaume Huguet, Richard Delorme, Thomas Bourgeron, The emerging role of SHANK genes in neuropsychiatric disorders, Developmental Neurobiology, 2014, 74, 2
  8. 8
    Konrad Talbot, Hoau-Yan Wang, The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease, Alzheimer's & Dementia, 2014, 10, 1, S12

    CrossRef

  9. 9
    Chiara Verpelli, Christopher Heise, Carlo Sala, The Synapse, 2014,

    CrossRef

  10. 10
    Chadwick M. Hales, Howard Rees, Nicholas T. Seyfried, Eric B. Dammer, Duc M. Duong, Marla Gearing, Thomas J. Montine, Juan C. Troncoso, Madhav Thambisetty, Allan I. Levey, James J. Lah, Thomas S. Wingo, Abnormal Gephyrin Immunoreactivity Associated With Alzheimer Disease Pathologic Changes, Journal of Neuropathology & Experimental Neurology, 2013, 72, 11, 1009

    CrossRef

  11. 11
    S. E. Lesne, M. A. Sherman, M. Grant, M. Kuskowski, J. A. Schneider, D. A. Bennett, K. H. Ashe, Brain amyloid-  oligomers in ageing and Alzheimer's disease, Brain, 2013, 136, 5, 1383

    CrossRef

  12. 12
    Mak Adam Daulatzai, Neurotoxic Saboteurs: Straws that Break the Hippo’s (Hippocampus) Back Drive Cognitive Impairment and Alzheimer’s Disease, Neurotoxicity Research, 2013, 24, 3, 407

    CrossRef

  13. 13
    Ting Yang, Soyon Hong, Tiernan O'Malley, Reisa A. Sperling, Dominic M. Walsh, Dennis J. Selkoe, New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF, Alzheimer's & Dementia, 2013, 9, 2, 99

    CrossRef

  14. 14
    Iñaki-Carril Mundiñano, Maria Hernandez, Carla DiCaudo, Cristina Ordoñez, Irene Marcilla, Maria-Teresa Tuñon, Maria-Rosario Luquin, Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys, Acta Neuropathologica, 2013, 126, 3, 411

    CrossRef

  15. 15
    Jochen Klucken, Anne-Maria Poehler, Darius Ebrahimi-Fakhari, Jacqueline Schneider, Silke Nuber, Edward Rockenstein, Ursula Schlötzer-Schrehardt, Bradley T. Hyman, Pamela J. McLean, Eliezer Masliah, Juergen Winkler, Alpha-synuclein aggregation involves a bafilomycin A1-sensitive autophagy pathway, Autophagy, 2012, 8, 5, 754

    CrossRef

  16. 16
    Siddhartha Mondragón-Rodríguez, George Perry, Xiongwei Zhu, Jannic Boehm, Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer’s Disease Treatment: Rethinking the Current Strategy, International Journal of Alzheimer's Disease, 2012, 2012, 1

    CrossRef

  17. 17
    Andrea Bartolomeis, Carmine Tomasetti, Calcium-Dependent Networks in Dopamine–Glutamate Interaction: The Role of Postsynaptic Scaffolding Proteins, Molecular Neurobiology, 2012, 46, 2, 275

    CrossRef

  18. 18
    Konrad Talbot, Hoau-Yan Wang, Hala Kazi, Li-Ying Han, Kalindi P. Bakshi, Andres Stucky, Robert L. Fuino, Krista R. Kawaguchi, Andrew J. Samoyedny, Robert S. Wilson, Zoe Arvanitakis, Julie A. Schneider, Bryan A. Wolf, David A. Bennett, John Q. Trojanowski, Steven E. Arnold, Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline, Journal of Clinical Investigation, 2012, 122, 4, 1316

    CrossRef

  19. 19
    Karim A. Alkadhi, Karem H. Alzoubi, Marisa Srivareerat, Trinh T. Tran, Elevation of BACE in an Aβ rat model of Alzheimer's disease: exacerbation by chronic stress and prevention by nicotine, The International Journal of Neuropsychopharmacology, 2012, 15, 02, 223

    CrossRef

  20. 20
    Grace Y. Sun, Yan He, Dennis Y. Chuang, James C. Lee, Zezong Gu, Agnes Simonyi, Albert Y. Sun, Integrating Cytosolic Phospholipase A2 with Oxidative/Nitrosative Signaling Pathways in Neurons: A Novel Therapeutic Strategy for AD, Molecular Neurobiology, 2012, 46, 1, 85

    CrossRef

  21. 21
    Chiyuki Matsui, Eiji Inoue, Akiyoshi Kakita, Kohei Arita, Maki Deguchi-Tawarada, Aki Togawa, Akio Yamada, Yoshimi Takai, Hitoshi Takahashi, Involvement of the γ-Secretase-Mediated EphA4 Signaling Pathway in Synaptic Pathogenesis of Alzheimer's Disease, Brain Pathology, 2012, 22, 6
  22. 22
    Valentina Gatta, Alberto Granzotto, Karina Fincati, Denise Drago, Silvia Bolognin, Paolo Zatta, Stefano L Sensi, Microarray analysis of gene expression profiles in human neuroblastoma cells exposed to Aβ–Zn and Aβ–Cu complexes, Future Neurology, 2012, 7, 4, 483

    CrossRef

  23. 23
    Elliott J. Mufson, Lester Binder, Scott E. Counts, Steven T. DeKosky, Leyla deToledo-Morrell, Stephen D. Ginsberg, Milos D. Ikonomovic, Sylvia E. Perez, Stephen W. Scheff, Mild cognitive impairment: pathology and mechanisms, Acta Neuropathologica, 2012, 123, 1, 13

    CrossRef

  24. 24
    Julia Kofler, Brian Lopresti, Chris Janssen, Anita M Trichel, Eliezer Masliah, Olivera J Finn, Russell D Salter, Geoffrey H Murdoch, Chester A Mathis, Clayton A Wiley, Preventive immunization of aged and juvenile non-human primates to beta-amyloid, Journal of Neuroinflammation, 2012, 9, 1, 84

    CrossRef

  25. 25
    Michal Schnaider Beeri, Vahram Haroutunian, James Schmeidler, Mary Sano, Peter Fam, Aaron Kavanaugh, Alasdair M. Barr, William G. Honer, Pavel Katsel, Synaptic protein deficits are associated with dementia irrespective of extreme old age, Neurobiology of Aging, 2012, 33, 6, 1125.e1

    CrossRef

  26. 26
    B C M Stephan, S Hunter, D Harris, D J Llewellyn, M Siervo, F E Matthews, C Brayne, The neuropathological profile of mild cognitive impairment (MCI): a systematic review, Molecular Psychiatry, 2012, 17, 11, 1056

    CrossRef

  27. 27
    Andreas M Grabrucker, Michael J Schmeisser, Patrick T Udvardi, Magali Arons, Michael Schoen, Nathaniel S Woodling, Katrin I Andreasson, Patrick R Hof, Joseph D Buxbaum, Craig C Garner, Tobias M Boeckers, Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold, Molecular Neurodegeneration, 2011, 6, 1, 65

    CrossRef

  28. 28
    Daniel Paris, David Beaulieu-Abdelahad, Corbin Bachmeier, Jon Reed, Ghania Ait-Ghezala, Alex Bishop, Jin Chao, Venkat Mathura, Fiona Crawford, Michael Mullan, Anatabine lowers Alzheimer's Aβ production in vitro and in vivo, European Journal of Pharmacology, 2011, 670, 2-3, 384

    CrossRef

  29. 29
    Edward Rockenstein, Kiren Ubhi, Emiley Pham, Sarah Michael, Edith Doppler, Philipp Novak, Chandra Inglis, Michael Mante, Anthony Adame, X. Anton Alvarez, Herbert Moessler, Eliezer Masliah, Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease, Journal of Neuroscience Research, 2011, 89, 11
  30. 30
    Andreas M Grabrucker, Mary J Knight, Christian Proepper, Juergen Bockmann, Marisa Joubert, Magali Rowan, G UIrich Nienhaus, Craig C Garner, Jim U Bowie, Michael R Kreutz, Eckart D Gundelfinger, Tobias M Boeckers, Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation, The EMBO Journal, 2011, 30, 3
  31. 31
    M. Manczak, M. J. Calkins, P. H. Reddy, Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage, Human Molecular Genetics, 2011, 20, 13, 2495

    CrossRef

  32. 32
    Christina Patrick, Leslie Crews, Paula Desplats, Wilmar Dumaop, Edward Rockenstein, Cristian L. Achim, Ian P. Everall, Eliezer Masliah, Increased CDK5 Expression in HIV Encephalitis Contributes to Neurodegeneration via Tau Phosphorylation and Is Reversed with Roscovitine, The American Journal of Pathology, 2011, 178, 4, 1646

    CrossRef

  33. 33
    Montse Morell, Natalia S. de Groot, Josep Vendrell, Francesc X. Avilés, Salvador Ventura, Linking amyloid protein aggregation and yeast survival, Molecular BioSystems, 2011, 7, 4, 1121

    CrossRef

  34. 34
    Hwan Goo Lee, Sun Mi Won, Byoung Joo Gwag, Yong Beom Lee, Microglial P2X7receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease, Experimental and Molecular Medicine, 2011, 43, 1, 7

    CrossRef

  35. 35
    Andreas M. Grabrucker, Michael J. Schmeisser, Michael Schoen, Tobias M. Boeckers, Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies, Trends in Cell Biology, 2011, 21, 10, 594

    CrossRef

  36. 36
    Yan He, Jiankun Cui, James C-M Lee, Shinghua Ding, Malgorzata Chalimoniuk, Agnes Simonyi, Albert Y Sun, Zezong Gu, Gary A Weisman∥, W Gibson Wood, Grace Y Sun, Prolonged exposure of cortical neurons to oligomeric amyloid-β impairs NMDA receptor function via NADPH oxidase-mediated ROS production: protective effect of green tea (–)-epigallocatechin-3-gallate, ASN NEURO, 2011, 3, 1, 13

    CrossRef

  37. 37
    Kiren Ubhi, Eliezer Masliah, Recent advances in the development of immunotherapies for tauopathies, Experimental Neurology, 2011, 230, 2, 157

    CrossRef

  38. 38
    M. Jin, N. Shepardson, T. Yang, G. Chen, D. Walsh, D. J. Selkoe, Soluble amyloid  -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration, Proceedings of the National Academy of Sciences, 2011, 108, 14, 5819

    CrossRef